Ellomay Capital Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated October 26, 2020, reports on the completion of a public offering in Israel for Ellomay Capital Ltd. The filing details the results of a classified and institutional bidding process held on October 22, 2020, for Series C Debentures and a new series of options (Series 1 Options).
Key Financial Metrics and Capital Raise
- Debt Issuance: Aggregate principal amount of NIS 154 million in Series C Debentures.
- Equity Derivatives: Issuance of 385,000 Series 1 Options.
- Unit Structure: Each unit consists of NIS 2,000 par value Series C Debentures and 5 Series 1 Options.
- Offering Price: NIS 2,132 per unit.
- Gross Proceeds: Approximately NIS 164.2 million.
- Net Proceeds: Approximately NIS 162.4 million (approx. $48.1 million) after expenses and commissions.
- Potential Additional Proceeds: Up to NIS 57.75 million if all Series 1 Options are exercised.
- Option Terms: Exercise price of NIS 150 (approx. $44.4) per share; valid through October 15, 2024.
Material Changes and Liquidity
The filing does not provide comparative financial metrics (revenue, profit, or margins) for the period. The primary material change is the significant increase in liquidity and capital resources resulting from the successful completion of the offering. The filing references the Company's 2019 Form 20-F for historical details on Series C Debentures.
Outlook, Risks, and Contingencies
Forward-Looking Statements: The report contains forward-looking statements regarding the Company's plans and expectations, which are subject to risks and uncertainties. Actual results may differ materially.
Geographic and Regulatory Restrictions: The offering was conducted exclusively in Israel and was not made to U.S. persons. The securities are not registered under the U.S. Securities Act of 1933 and cannot be offered or sold in the United States without registration or an applicable exemption.
Contingencies: Additional proceeds of NIS 57.75 million are contingent upon the full exercise of the Series 1 Options prior to their expiration date.
Key Facts for Investor Verification
- Verify the actual net proceeds received versus the estimated NIS 162.4 million.
- Confirm the listing status of the Series 1 Options on the Tel Aviv Stock Exchange.
- Review the 2019 Form 20-F for detailed terms and covenants regarding the Series C Debentures.
- Monitor the exercise rate of the Series 1 Options to assess potential future equity dilution and additional capital inflow.
- Ensure compliance with U.S. securities laws regarding the non-registration of these specific instruments for U.S. investors.